| CAS ID: | 55837-20-2 |
| Molecular Formula: | C16H17BrClN3O3 |
| Molecular Weight: | 414.7 g/mol |
| Monoisotopic Mass: | 413.0142 g/mol |
| Class: | Small Molecule |
| Natural Product: | Yes |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 28487390 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting amino acid response pathway | ||
Reference Record 2
| PubMed ID | 23274062 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Muscle fibrosis |
| Process I | |||
| Process II | cells migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β signaling | ||
Reference Record 3
| PubMed ID | 22327401 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 4
Reference Record 5
| PubMed ID | 12482197 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 6
| PubMed ID | 11705455 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Dermal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 7
Reference Record 8
Reference Record 9
| PubMed ID | 29065190 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Scleroderma |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
| PubChem: | 400772 |
| ChEMBL: | CHEMBL1199539 |